Cybin Upsizes Bought Deal Financing To $30.0 Million

Cybin Inc (NEO: CYBN) has upsized its previously announced $20.0 million bought deal financing. The financing, following strong investor demand, has now been upsized to $30.0 million.

The financing, led by Canaccord Genuity, will see the sale of 13.3 million units of the company at a price of $2.25 per unit. Each unit contains one common share and one half of a common share purchase warrant. Each whole warrant is valid for a period of three years from the date of issuance, with an exercise price of $3.25 per share.

Warrants issued under the offering are also subject to an acceleration clause, whereby the company can force the acceleration of the expiry date upon the equity trading above $5.00 per share on a volume weighted basis for a period of ten consecutive trading days. A 15% over-allotment option has also been granted by the underwriters.

Net proceeds from the financing are to be used for clinical trials, novel molecule programs and tech focused on the patient experience, as well as working capital and general corporate purposes.

Cybin Inc last traded at $2.28 on the Neo.


Information for this briefing was found via Sedar and Cybin Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Cybin: Eight Capital Initiates With $8.15 Price Target

Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes...

Saturday, September 18, 2021, 04:14:00 PM

Psychedelics: The Eight Capital Primer

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are...

Monday, June 14, 2021, 03:38:00 PM

Cybin: Canaccord Bumps Price Target To US$7.00

Cybin Inc (NEO: CYBN) last month had a long month of news reports, the first...

Thursday, September 2, 2021, 11:16:00 AM

Cybin Looks To Raise $20.0 Million Via Bought Deal

Cybin Inc (NEO: CYBN) this morning became the latest firm to take advantage of the...

Monday, January 18, 2021, 06:59:03 AM